Compare Batavia Prosperindo Trans Tbk (BPTR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Batavia Prosperindo Trans Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Batavia Prosperindo Trans Tbk trades at Rp75 (market cap 265.05B), while UBC Medical Indonesia Tbk. trades at Rp161 (market cap 635.95B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.4× Batavia Prosperindo Trans Tbk's market cap. Which is the better fit depends on your goals.
| BPTR | LABS | |
|---|---|---|
Market Cap | 265.05B | 635.95B |
Indicative Equilibrium Price | 76 | 163 |
Indicative Equilibrium Volume | 50 | 16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Batavia Prosperindo Trans Tbk
PT Batavia Prosperindo Trans (the “Company”) was established based on Deed No. 20 dated December 8, 2014 of Devi Yuana Lisa, S.H., as substitute Notary of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., Notary in Jakarta.
Read more on BPTR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
